Mural Oncology plc financial data

Symbol
MURA on Nasdaq
Location
10 Earlsfort Terrace, Dublin 2, Ireland
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 522 % -28%
Debt-to-equity 23.1 % +19.9%
Return On Equity -122 % -22.9%
Return On Assets -99.4 % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.3M shares +1.68%
Common Stock, Shares, Outstanding 17.3M shares +2.05%
Common Stock, Value, Issued 173K USD +2.37%
Weighted Average Number of Shares Outstanding, Basic 17.3M shares +2.05%
Weighted Average Number of Shares Outstanding, Diluted 17.3M shares +2.05%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 107M USD -21.9%
General and Administrative Expense 28.7M USD -20.5%
Operating Income (Loss) -153M USD +11.5%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -147M USD +15.1%
Earnings Per Share, Basic -8 USD/shares +16.9%
Earnings Per Share, Diluted -8 USD/shares +16.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 77.1M USD -36.6%
Other Assets, Current 972K USD +54.8%
Assets, Current 81.6M USD -61.7%
Property, Plant and Equipment, Net 1.64M USD -83.1%
Operating Lease, Right-of-Use Asset 4.36M USD -56.9%
Other Assets, Noncurrent 3K USD -96.1%
Assets 87.6M USD -62.7%
Accounts Payable, Current 3.14M USD +1.09%
Employee-related Liabilities, Current 4.71M USD +3.54%
Accrued Liabilities, Current 20.2M USD +25.1%
Liabilities, Current 28.4M USD +15.4%
Operating Lease, Liability, Noncurrent 166K USD -97.1%
Other Liabilities, Noncurrent 188K USD
Liabilities 28.8M USD -5.22%
Retained Earnings (Accumulated Deficit) -240M USD -158%
Stockholders' Equity Attributable to Parent 58.8M USD -71.3%
Liabilities and Equity 87.6M USD -62.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.8M USD +1.45%
Net Cash Provided by (Used in) Financing Activities 28M USD
Net Cash Provided by (Used in) Investing Activities 28M USD
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 17.3M shares +2.05%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.78M USD +94.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 79.1M USD -36%
Operating Lease, Liability 5.17M USD -53.3%
Depreciation 3.72M USD +20.6%
Payments to Acquire Property, Plant, and Equipment 10K USD -81.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -147M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid 5.27M USD -54.2%
Property, Plant and Equipment, Gross 33.9M USD -24.9%
Operating Lease, Liability, Current 5.01M USD -6.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.48M USD -62.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 99K USD -76.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 299M USD +0.44%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.08M USD -95%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%